Differential Complete Blood Count for Diagnosis of COVID-19?

Differential Complete Blood Count for Diagnosis of COVID-19?

Nermine A. Melek (1), Mohamed F. Allam (2,3), Bassem G. Labib (1), Abdalla Bazazo (2), Mayada M. Mahmoud (1) and Omneya M. Zeada (1)

1. Department of Internal Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt

2. Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt

3. Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, October 6 University, Cairo, Egypt

World Journal of Medical Microbiology, 2023, 2, 689

DOI: 10.31586/wjmm.2023.689

 

Abstract

Background: The World Health Organization (WHO) has declared COVID-19 a public health emergency of international concern. In this context, effective and affordable diagnostic procedures are essential for identifying and managing cases. Complete blood counts (CBC) are among the most common and readily available diagnostic tests. The current study aimed to evaluate the efficacy of CBC in diagnosing COVID-19 and identifying cases. Patients and Methods: A case-control study was conducted on 173 patients at Ain Shams University Hospitals over a period of three months. Patients were allocated into two groups according to COVID-19 PCR results: Group 1 included patients with COVID-19 positive PCR, and Group 2 included patients with COVID-19 negative PCR. Results: The study found that differential CBC had significant value in diagnosing COVID-19 disease. Many COVID-19 patients had lymphopenia and leucopenia compared to non-COVID-19 suspected patients. The low values of leukocytes, neutrophils, lymphocytes, and eosinophils with a CBC test were found to be valuable in the initial diagnosis of COVID-19. Conclusion: The definitive diagnosis of COVID-19 requires RT-PCR analysis, which is time-consuming and less accessible. Thus, the initial diagnosis and treatment of patients may be delayed. This study suggests that CBC, which is easily available and affordable, can be valuable in the early identification of COVID-19 cases, allowing for prompt treatment and management.

 

Keywords: Complete blood count, COVID-19, Diagnosis, Case control study, Leucopenia, Lymphopenia.

 

World Journal of Medical Microbiology, 2023, 2, 689

https://www.scipublications.com/journal/index.php/WJMM/article/view/689